Pressure Biosciences Inc Sample Contracts

Exhibit 4.8
Boston Biomedica Inc • September 8th, 2000 • In vitro & in vivo diagnostic substances • Massachusetts
AutoNDA by SimpleDocs
RECITALS
Voting Agreement • April 16th, 2004 • Boston Biomedica Inc • In vitro & in vivo diagnostic substances • Delaware
Names of Subscribers: Richard P. Kiphart Andrew Gluck David Valentine Rebecca Kiphart Arthur Hill SUBSCRIPTION AGREEMENT Boston Biomedica, Inc. 375 West Street West Bridgewater, Massachusetts 02379 December 6, 2001 Gentlemen:
Subscription Agreement • April 1st, 2002 • Boston Biomedica Inc • In vitro & in vivo diagnostic substances • Massachusetts

The undersigned persons (collectively, the “Investors”), by executing this Subscription Agreement, hereby subscribe for the number of shares of Common Stock, $0.01 par value per share (the “Common Stock”), of Boston Biomedica, Inc., a Massachusetts corporation (the “Company”) set forth in paragraph 2 and agree to be bound by the terms and conditions hereof.

DATED AS OF AUGUST 25, 2000 BY AND BETWEEN
Securities Purchase Agreement • September 8th, 2000 • Boston Biomedica Inc • In vitro & in vivo diagnostic substances • Massachusetts
ASSET PURCHASE AGREEMENT
Asset Purchase Agreement • March 8th, 2001 • Boston Biomedica Inc • In vitro & in vivo diagnostic substances • California
Exhibit 1 ASSET PURCHASE AGREEMENT
Asset Purchase Agreement • April 16th, 2004 • Boston Biomedica Inc • In vitro & in vivo diagnostic substances • Delaware
1,600,000 Shares* Boston Biomedica, Inc. Common Stock UNDERWRITING AGREEMENT
Boston Biomedica Inc • October 25th, 1996 • In vitro & in vivo diagnostic substances • New York
Exhibit 4.3
Boston Biomedica Inc • September 8th, 2000 • In vitro & in vivo diagnostic substances • Massachusetts
EXHIBIT 10.8 LEASE
Boston Biomedica Inc • October 25th, 1996 • In vitro & in vivo diagnostic substances • Connecticut
Exhibit 4.10
Registration Rights Agreement • September 8th, 2000 • Boston Biomedica Inc • In vitro & in vivo diagnostic substances • Massachusetts
Exhibit 4.2
Securities Purchase Agreement • September 8th, 2000 • Boston Biomedica Inc • In vitro & in vivo diagnostic substances • Massachusetts
Exhibit 4 AMENDMENT NO. 1 TO RIGHTS AGREEMENT
Rights Agreement • April 16th, 2004 • Boston Biomedica Inc • In vitro & in vivo diagnostic substances
WITNESSETH
License Agreement • March 30th, 2000 • Boston Biomedica Inc • In vitro & in vivo diagnostic substances
COMMON STOCK PURCHASE WARRANT PRESSURE BIOSCIENCES, INC. WARRANT NO. F-__
Common Stock Purchase Warrant • November 10th, 2011 • Pressure Biosciences Inc • Measuring & controlling devices, nec

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after May ___, 2012 (the “Initial Exercise Date”) and on or prior to the close of business on the five year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Pressure BioSciences, Inc., a Massachusetts corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock of the Company, par value $0.01 per share (the “Common Stock”). The purchase price of one Warrant Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

10% SENIOR SECURED CONVERTIBLE PROMISSORY NOTE
Pressure Biosciences Inc • December 30th, 2019 • Laboratory analytical instruments • New York

THIS 10% SENIOR SECURED CONVERTIBLE PROMISSORY NOTE is duly authorized and validly issued by Pressure BioSciences, Inc., a Massachusetts corporation, (the “Company”), designated as its 10% Senior Secured Convertible Promissory Note due 2020 (this note, the “Note” and, collectively with any other notes of such series, the “Notes”). The Notes are secured by a General Security Agreement between the Company and the Holder, dated of even date herewith.

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • November 10th, 2011 • Pressure Biosciences Inc • Measuring & controlling devices, nec • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of November 8, 2011, between Pressure Biosciences, Inc., a Massachusetts corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • May 16th, 2017 • Pressure Biosciences Inc • Laboratory analytical instruments • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of March ___, 2017, between Pressure BioSciences, Inc. a Massachusetts corporation (the “Company”), and the purchaser identified on the signature pages hereto (including its successors and assigns, the “Purchaser”).

AGREEMENT
Agreement • October 25th, 1996 • Boston Biomedica Inc • In vitro & in vivo diagnostic substances • Maryland
AutoNDA by SimpleDocs
Contract
Pressure Biosciences Inc • April 24th, 2017 • Laboratory analytical instruments • New York

NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY AND THE SECURITIES ISSUABLE UPON CONVERSION OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES, UNLESS OTHERWISE PROHIBITED BY FEDERAL OR STATE SECURITIE

DATED AS OF
Securities Purchase Agreement • September 8th, 2000 • Boston Biomedica Inc • In vitro & in vivo diagnostic substances • Massachusetts
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • December 30th, 2019 • Pressure Biosciences Inc • Laboratory analytical instruments • New York

This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of the date listed on the signature pages hereto, is by and among Pressure BioSciences, Inc., a Massachusetts corporation (the “Company”), and each of the undersigned buyers (each, a “Buyer,” and collectively, the “Buyers”).

COMMON STOCK PURCHASE WARRANT PRESSURE BIOSCIENCES, INC.
Pressure Biosciences Inc • April 5th, 2022 • Laboratory analytical instruments • New York

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, XXXXXXXXX or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after XXXXXXXXX (the “Initial Exercise Date”) and on or prior to the close of business on the X-year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Pressure BioSciences, Inc., a Massachusetts corporation (the “Company”), up to XXXXXX shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

UNDERWRITING AGREEMENT Between PRESSURE BIOSCIENCES, INC. and JOSEPH GUNNAR & CO., LLC as Representative of the Several Underwriters PRESSURE BIOSCIENCES, INC. UNDERWRITING AGREEMENT
Underwriting Agreement • August 10th, 2017 • Pressure Biosciences Inc • Laboratory analytical instruments • New York

The undersigned, Pressure BioSciences, Inc., a corporation formed under the laws of the Commonwealth of Massachusetts (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of Pressure BioSciences, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with Joseph Gunnar & Co., LLC. (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:

WARRANT AGENT AGREEMENT
Warrant Agent Agreement • August 10th, 2017 • Pressure Biosciences Inc • Laboratory analytical instruments • New York

WARRANT AGENT AGREEMENT (this “Warrant Agreement”) dated as of _________, 2017 (the “Issuance Date”) between Pressure BioSciences, Inc., a company incorporated under the laws of the Commonwealth of Massachusetts (the “Company”), and Computershare Trust Company, N.A. (the “Warrant Agent”).

PLACEMENT AGENCY AGREEMENT April 6, 2012
Placement Agency Agreement • April 9th, 2012 • Pressure Biosciences Inc • Measuring & controlling devices, nec • New York
Exhibit 4.9
Boston Biomedica Inc • September 8th, 2000 • In vitro & in vivo diagnostic substances
COMMON STOCK PURCHASE WARRANT PRESSURE BIOSCIENCES, INC.
Pressure Biosciences Inc • November 3rd, 2016 • Laboratory analytical instruments • Massachusetts

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ______ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after ______ (the “Initial Exercise Date”) and on or prior to the close of business on the five year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Pressure BioSciences, Inc., a Massachusetts corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 1(b).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!